UBS Group’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.4M Buy
864,328
+15,420
+2% +$653K ﹤0.01% 2040
2026
Q1
$33.1M Buy
848,908
+332,559
+64% +$13.5M 0.01% 2071
2025
Q4
$21.1M Buy
516,349
+12,034
+2% +$490K ﹤0.01% 2542
2025
Q3
$20.3M Buy
504,315
+137,361
+37% +$5.29M ﹤0.01% 2543
2025
Q2
$13.5M Buy
366,954
+225,803
+160% +$7.65M ﹤0.01% 2796
2025
Q1
$4.69M Buy
141,151
+139,698
+9,614% +$4.86M ﹤0.01% 3844
2024
Q4
$50.3K Buy
1,453
+1,291
+797% +$45.3K ﹤0.01% 7288
2024
Q3
$5.49K Buy
+162
New +$5.3K ﹤0.01% 8049
2023
Q4
Sell
-1,862
Closed -$46.8K 9786
2023
Q3
$46.8K Buy
1,862
+1,542
+482% +$40K ﹤0.01% 6329
2023
Q2
$8.27K Buy
320
+220
+220% +$5.42K ﹤0.01% 7249
2023
Q1
$2.4K Buy
+100
New +$2.35K ﹤0.01% 8521

Other funds holding RECS

UBS Group's RECS Position: Q2 2026 in Review

UBS Group increased its Columbia Research Enhanced Core ETF (RECS) stake by 1.8% in Q2 2026, buying an estimated $653K and bringing the position to 864,328 shares worth $37.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2040.

UBS Group first reported a position in RECS in Q1 2023 and has held it in 11 quarters since. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • UBS Group held 864,328 shares of Columbia Research Enhanced Core ETF worth $37.4M as of Q2 2026.
  • UBS Group bought 15,420 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $653K.
  • Columbia Research Enhanced Core ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2040 holding.
  • UBS Group first reported a position in Columbia Research Enhanced Core ETF in Q1 2023 and has held it in 11 quarters since.
  • 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.